{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "36450832", "DateCompleted": {"Year": "2022", "Month": "12", "Day": "02"}, "DateRevised": {"Year": "2024", "Month": "06", "Day": "30"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "11", "Day": "30"}], "Language": ["eng"], "ELocationID": ["20680", "10.1038/s41598-022-24154-0"], "Journal": {"ISSN": "2045-2322", "JournalIssue": {"Volume": "12", "Issue": "1", "PubDate": {"Year": "2022", "Month": "Nov", "Day": "30"}}, "Title": "Scientific reports", "ISOAbbreviation": "Sci Rep"}, "ArticleTitle": "Structural analysis of the 2-oxoglutarate binding site of the circadian rhythm linked oxygenase JMJD5.", "Pagination": {"StartPage": "20680", "MedlinePgn": "20680"}, "Abstract": {"AbstractText": ["JmjC (Jumonji-C) domain-containing 5 (JMJD5) plays important roles in circadian regulation in plants and humans and is involved in embryonic development and cell proliferation. JMJD5 is a 2-oxoglutarate (2OG) and Fe(II) dependent oxygenase of the JmjC subfamily, which includes histone N<sup>\u03b5</sup>-methyl lysine-demethylases (KDMs) and hydroxylases catalysing formation of stable alcohol products. JMJD5 is reported to have KDM activity, but has been shown to catalyse C-3 hydroxylation of arginine residues in sequences from human regulator of chromosome condensation domain-containing protein 1 (RCCD1) and ribosomal protein S6 (RPS6) in vitro. We report crystallographic analyses of human JMJD5 complexed with 2OG analogues, including the widely used hypoxia mimic pyridine-2,4-dicarboxylate, both D- and L-enantiomers of the oncometabolite 2-hydroxyglutarate, and a cyclic N-hydroxyimide. The results support the assignment of JMJD5 as a protein hydroxylase and reveal JMJD5 has an unusually compact 2OG binding pocket suitable for exploitation in development of selective inhibitors. They will be useful in the development of chemical probes to investigate the physiologically relevant roles of JMJD5 in circadian rhythm and development and explore its potential as a medicinal chemistry target."], "CopyrightInformation": "\u00a9 2022. The Author(s)."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Chemistry Research Laboratory, Department of Chemistry and the Ineos Oxford Institute for Antimicrobial Research, University of Oxford, 12 Mansfield Road, Oxford, OX1 3TA, UK."}], "LastName": "Islam", "ForeName": "Md Saiful", "Initials": "MS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Chemistry Research Laboratory, Department of Chemistry and the Ineos Oxford Institute for Antimicrobial Research, University of Oxford, 12 Mansfield Road, Oxford, OX1 3TA, UK."}], "LastName": "Markoulides", "ForeName": "Marios", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Chemistry Research Laboratory, Department of Chemistry and the Ineos Oxford Institute for Antimicrobial Research, University of Oxford, 12 Mansfield Road, Oxford, OX1 3TA, UK. chowdhury.rzaman@gmail.com."}], "LastName": "Chowdhury", "ForeName": "Rasheduzzaman", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Chemistry Research Laboratory, Department of Chemistry and the Ineos Oxford Institute for Antimicrobial Research, University of Oxford, 12 Mansfield Road, Oxford, OX1 3TA, UK. christopher.schofield@chem.ox.ac.uk."}], "LastName": "Schofield", "ForeName": "Christopher J", "Initials": "CJ"}], "GrantList": [{"Acronym": "WT_", "Agency": "Wellcome Trust", "Country": "United Kingdom"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Sci Rep", "NlmUniqueID": "101563288", "ISSNLinking": "2045-2322"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Ketoglutaric Acids"}, {"RegistryNumber": "EC 1.13.-", "NameOfSubstance": "Oxygenases"}, {"RegistryNumber": "EC 1.-", "NameOfSubstance": "Mixed Function Oxygenases"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": [], "DescriptorName": "Pregnancy"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Ketoglutaric Acids"}, {"QualifierName": [], "DescriptorName": "Oxygenases"}, {"QualifierName": [], "DescriptorName": "Circadian Rhythm"}, {"QualifierName": [], "DescriptorName": "Psychotherapy"}, {"QualifierName": [], "DescriptorName": "Binding Sites"}, {"QualifierName": [], "DescriptorName": "Mixed Function Oxygenases"}], "CoiStatement": "The authors declare no competing interests."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Herr CQ, Hausinger RP. Amazing diversity in biochemical roles of Fe(II)/2-oxoglutarate oxygenases. Trends Biochem. Sci. 2018;43:517\u2013532. doi: 10.1016/j.tibs.2018.04.002.", "ArticleIdList": ["10.1016/j.tibs.2018.04.002", "PMC6014900", "29709390"]}, {"Citation": "Kaelin WG, Jr, Ratcliffe PJ. Oxygen sensing by metazoans: The central role of the HIF hydroxylase pathway. Mol. Cell. 2008;30:393\u2013402. doi: 10.1016/j.molcel.2008.04.009.", "ArticleIdList": ["10.1016/j.molcel.2008.04.009", "18498744"]}, {"Citation": "Markolovic S, et al. Structure\u2013function relationships of human JmjC oxygenases\u2014demethylases versus hydroxylases. Curr. Opin. Struct. Biol. 2016;41:62\u201372. doi: 10.1016/j.sbi.2016.05.013.", "ArticleIdList": ["10.1016/j.sbi.2016.05.013", "27309310"]}, {"Citation": "Islam MS, Leissing TM, Chowdhury R, Hopkinson RJ, Schofield CJ. 2-Oxoglutarate-dependent oxygenases. Annu. Rev. Biochem. 2018;87:585\u2013620. doi: 10.1146/annurev-biochem-061516-044724.", "ArticleIdList": ["10.1146/annurev-biochem-061516-044724", "29494239"]}, {"Citation": "Rose NR, McDonough MA, King ONF, Kawamura A, Schofield CJ. Inhibition of 2-oxoglutarate dependent oxygenases. Chem. Soc. Rev. 2011;40:4364\u20134397. doi: 10.1039/c0cs00203h.", "ArticleIdList": ["10.1039/c0cs00203h", "21390379"]}, {"Citation": "Maxwell PH, Eckardt K-U. HIF prolyl hydroxylase inhibitors for the treatment of renal anaemia and beyond. Nat. Rev. Nephrol. 2016;12:157\u2013168. doi: 10.1038/nrneph.2015.193.", "ArticleIdList": ["10.1038/nrneph.2015.193", "26656456"]}, {"Citation": "Chan MC, Holt-Martyn JP, Schofield CJ, Ratcliffe PJ. Pharmacological targeting of the HIF hydroxylases\u2013a new field in medicine development. Mol. Aspects Med. 2016;47\u201348:54\u201375. doi: 10.1016/j.mam.2016.01.001.", "ArticleIdList": ["10.1016/j.mam.2016.01.001", "26791432"]}, {"Citation": "Yeh T-L, et al. Molecular and cellular mechanisms of HIF prolyl hydroxylase inhibitors in clinical trials. Chem. Sci. 2017;8:7651\u20137668. doi: 10.1039/C7SC02103H.", "ArticleIdList": ["10.1039/C7SC02103H", "PMC5802278", "29435217"]}, {"Citation": "Thinnes CC, et al. Targeting histone lysine demethylases\u2013progress, challenges, and the future. Biochim. Biophys. Acta-Gene Regul. Mech. 2014;1839:1416\u20131432. doi: 10.1016/j.bbagrm.2014.05.009.", "ArticleIdList": ["10.1016/j.bbagrm.2014.05.009", "PMC4316176", "24859458"]}, {"Citation": "Dambrova M, Liepinsh E, Kalvinsh I. Mildronate: Cardioprotective action through carnitine-lowering effect. Trends Cardiovasc. Med. 2002;12:275\u2013279. doi: 10.1016/S1050-1738(02)00175-5.", "ArticleIdList": ["10.1016/S1050-1738(02)00175-5", "12242052"]}, {"Citation": "Dzerve, V. & Group, M. I. S. A dose-dependent improvement in exercise tolerance in patients with stable angina treated with mildronate: A clinical trial \u201cMILSS I\u201d. Medicina vol. 47 (2011).", "ArticleIdList": ["22186118"]}, {"Citation": "Rupp H, Zarain-Herzberg A, Maisch B. The use of partial fatty acid oxidation inhibitors for metabolic therapy of angina pectoris and heart failure. Herz. 2002;27:621\u2013636. doi: 10.1007/s00059-002-2428-x.", "ArticleIdList": ["10.1007/s00059-002-2428-x", "12439634"]}, {"Citation": "Rydzik AM, et al. Comparison of the substrate selectivity and biochemical properties of human and bacterial \u03b3-butyrobetaine hydroxylase. Org. Biomol. Chem. 2014;12:6354\u20136358. doi: 10.1039/C4OB01167H.", "ArticleIdList": ["10.1039/C4OB01167H", "25030770"]}, {"Citation": "Henry L, Leung IKH, Claridge TDW, Schofield CJ. \u03b3-Butyrobetaine hydroxylase catalyses a stevens type rearrangement. Bioorg. Med. Chem. Lett. 2012;22:4975\u20134978. doi: 10.1016/j.bmcl.2012.06.024.", "ArticleIdList": ["10.1016/j.bmcl.2012.06.024", "22765904"]}, {"Citation": "Clifton IJ, et al. Structural studies on 2-oxoglutarate oxygenases and related double-stranded \u03b2-helix fold proteins. J. Inorg. Biochem. 2006;100:644\u2013669. doi: 10.1016/j.jinorgbio.2006.01.024.", "ArticleIdList": ["10.1016/j.jinorgbio.2006.01.024", "16513174"]}, {"Citation": "Franklin TJ. Therapeutic approaches to organ fibrosis. Int. J. Biochem. Cell Biol. 1997;29:79\u201389. doi: 10.1016/S1357-2725(96)00121-5.", "ArticleIdList": ["10.1016/S1357-2725(96)00121-5", "9076943"]}, {"Citation": "Myllyharju, J. CHAPTER 5 Collagen Hydroxylases. In 2-Oxoglutarate-Dependent Oxygenases 149\u2013168 10.1039/9781782621959-00149 (The Royal Society of Chemistry, 2015)."}, {"Citation": "Myllyharju J, Kivirikko KI. Collagens and collagen-related diseases. Ann. Med. 2001;33:7\u201321. doi: 10.3109/07853890109002055.", "ArticleIdList": ["10.3109/07853890109002055", "11310942"]}, {"Citation": "Heinemann B, et al. Inhibition of demethylases by GSK-J1/J4. Nature. 2014;514:E1\u2013E2. doi: 10.1038/nature13688.", "ArticleIdList": ["10.1038/nature13688", "25279926"]}, {"Citation": "Horton JR, et al. Structural basis for KDM5A histone lysine demethylase inhibition by diverse compounds. Cell Chem. Biol. 2016;23:769\u2013781. doi: 10.1016/j.chembiol.2016.06.006.", "ArticleIdList": ["10.1016/j.chembiol.2016.06.006", "PMC4958579", "27427228"]}, {"Citation": "Kampranis, S. C. & Tsichlis, P. N. B. T.-A. In C. R. Chapter 4 Histone Demethylases and Cancer. In vol. 102 103\u2013169 (Academic Press, 2009).", "ArticleIdList": ["PMC3505602", "19595308"]}, {"Citation": "Kim MS, et al. JIB-04, A small molecule histone demethylase inhibitor, selectively targets colorectal cancer stem cells by inhibiting the Wnt/\u03b2-Catenin signaling pathway. Sci. Rep. 2018;8:6611. doi: 10.1038/s41598-018-24903-0.", "ArticleIdList": ["10.1038/s41598-018-24903-0", "PMC5919936", "29700375"]}, {"Citation": "Miyake Y, et al. Identification of novel lysine demethylase 5-selective inhibitors by inhibitor-based fragment merging strategy. Bioorg. Med. Chem. 2019;27:1119\u20131129. doi: 10.1016/j.bmc.2019.02.006.", "ArticleIdList": ["10.1016/j.bmc.2019.02.006", "30745098"]}, {"Citation": "Rotili D, Mai A. Targeting histone demethylases: A new avenue for the fight against cancer. Genes Cancer. 2011;2:663\u2013679. doi: 10.1177/1947601911417976.", "ArticleIdList": ["10.1177/1947601911417976", "PMC3174264", "21941621"]}, {"Citation": "Tumber A, et al. Potent and selective KDM5 inhibitor stops cellular demethylation of H3K4me3 at transcription start sites and proliferation of MM1S myeloma cells. Cell Chem. Biol. 2017;24:371\u2013380. doi: 10.1016/j.chembiol.2017.02.006.", "ArticleIdList": ["10.1016/j.chembiol.2017.02.006", "PMC5361737", "28262558"]}, {"Citation": "McDonough MA, et al. Selective inhibition of factor inhibiting hypoxia-inducible factor. J. Am. Chem. Soc. 2005;127:7680\u20137681. doi: 10.1021/ja050841b.", "ArticleIdList": ["10.1021/ja050841b", "15913349"]}, {"Citation": "He Z, et al. JMJD5 (jumonji domain-containing 5) associates with spindle microtubules and is required for proper mitosis*. J. Biol. Chem. 2016;291:4684\u20134697. doi: 10.1074/jbc.M115.672642.", "ArticleIdList": ["10.1074/jbc.M115.672642", "PMC4813491", "26710852"]}, {"Citation": "Wilkins SE, et al. JMJD5 is a human arginyl C-3 hydroxylase. Nat. Commun. 2018;9:1180. doi: 10.1038/s41467-018-03410-w.", "ArticleIdList": ["10.1038/s41467-018-03410-w", "PMC5862942", "29563586"]}, {"Citation": "Liu, H. et al. The Novel Protease Activities of JMJD5-JMJD6-JMJD7 and Arginine Methylation Activities of Arginine Methyltransferases Are Likely Coupled. Biomolecules vol. 12 (2022).", "ArticleIdList": ["PMC8945206", "35327545"]}, {"Citation": "Oh S, Janknecht R. Histone demethylase JMJD5 is essential for embryonic development. Biochem. Biophys. Res. Commun. 2012;420:61\u201365. doi: 10.1016/j.bbrc.2012.02.115.", "ArticleIdList": ["10.1016/j.bbrc.2012.02.115", "22402282"]}, {"Citation": "Jones MA, et al. Jumonji domain protein JMJD5 functions in both the plant and human circadian systems. Proc. Natl. Acad. Sci. 2010;107:21623\u201321628. doi: 10.1073/pnas.1014204108.", "ArticleIdList": ["10.1073/pnas.1014204108", "PMC3003042", "21115819"]}, {"Citation": "Haolin L, et al. JMJD5 couples with CDK9 to release the paused RNA polymerase II. Proc. Natl. Acad. Sci. 2020;117:19888\u201319895. doi: 10.1073/pnas.2005745117.", "ArticleIdList": ["10.1073/pnas.2005745117", "PMC7443887", "32747552"]}, {"Citation": "Liu S, Cadoux-Hudson T, Schofield CJ. Isocitrate dehydrogenase variants in cancer\u2013cellular consequences and therapeutic opportunities. Curr. Opin. Chem. Biol. 2020;57:122\u2013134. doi: 10.1016/j.cbpa.2020.06.012.", "ArticleIdList": ["10.1016/j.cbpa.2020.06.012", "PMC7487778", "32777735"]}, {"Citation": "Pirozzi CJ, Yan H. The implications of IDH mutations for cancer development and therapy. Nat. Rev. Clin. Oncol. 2021;18:645\u2013661. doi: 10.1038/s41571-021-00521-0.", "ArticleIdList": ["10.1038/s41571-021-00521-0", "34131315"]}, {"Citation": "Chowdhury R, et al. The oncometabolite 2-hydroxyglutarate inhibits histone lysine demethylases. EMBO Rep. 2011;12:463\u2013469. doi: 10.1038/embor.2011.43.", "ArticleIdList": ["10.1038/embor.2011.43", "PMC3090014", "21460794"]}, {"Citation": "Johnson BM, Stier BA, Caltabiano S. Effect of food and gemfibrozil on the pharmacokinetics of the novel prolyl hydroxylase inhibitor GSK1278863. Clin. Pharmacol. Drug Dev. 2014;3:109\u2013117. doi: 10.1002/cpdd.83.", "ArticleIdList": ["10.1002/cpdd.83", "27128455"]}, {"Citation": "Yu, L. et al. Targeting the JMJD2 histone demethylases to epigenetically control herpesvirus infection and reactivation from latency. Sci. Transl. Med.5, 167ra5\u2013167ra5 (2013).", "ArticleIdList": ["PMC4778723", "23303604"]}, {"Citation": "Hopkinson RJ, et al. 5-Carboxy-8-hydroxyquinoline is a broad spectrum 2-oxoglutarate oxygenase inhibitor which causes iron translocation. Chem. Sci. 2013;4:3110\u20133117. doi: 10.1039/c3sc51122g.", "ArticleIdList": ["10.1039/c3sc51122g", "PMC4678600", "26682036"]}, {"Citation": "Rose NR, et al. Inhibitor scaffolds for 2-oxoglutarate-dependent histone lysine demethylases. J. Med. Chem. 2008;51:7053\u20137056. doi: 10.1021/jm800936s.", "ArticleIdList": ["10.1021/jm800936s", "18942826"]}, {"Citation": "Woon ECY, et al. Dynamic combinatorial mass spectrometry leads to inhibitors of a 2-oxoglutarate-dependent nucleic acid demethylase. J. Med. Chem. 2012;55:2173\u20132184. doi: 10.1021/jm201417e.", "ArticleIdList": ["10.1021/jm201417e", "22263962"]}, {"Citation": "Rose NR, et al. Selective inhibitors of the JMJD2 histone demethylases: combined nondenaturing mass spectrometric screening and crystallographic approaches. J. Med. Chem. 2010;53:1810\u20131818. doi: 10.1021/jm901680b.", "ArticleIdList": ["10.1021/jm901680b", "PMC2825117", "20088513"]}, {"Citation": "Del Rizzo, P. A. Swathi, K. & Trievel. R. C. Crystal structure and functional analysis of JMJD5 indicate an alternate specificity and function. Mol. Cell. Biol.32, 4044\u20134052 (2012).", "ArticleIdList": ["PMC3457536", "22851697"]}, {"Citation": "Conejo-Garcia A, et al. Structural basis for binding of cyclic 2-oxoglutarate analogues to factor-inhibiting hypoxia-inducible factor. Bioorg. Med. Chem. Lett. 2010;20:6125\u20136128. doi: 10.1016/j.bmcl.2010.08.032.", "ArticleIdList": ["10.1016/j.bmcl.2010.08.032", "20822901"]}, {"Citation": "Schlemminger I, et al. Analogues of dealanylalahopcin are inhibitors of human HIF prolyl hydroxylases. Bioorg. Med. Chem. Lett. 2003;13:1451\u20131454. doi: 10.1016/S0960-894X(03)00149-5.", "ArticleIdList": ["10.1016/S0960-894X(03)00149-5", "12668010"]}, {"Citation": "Horii S, et al. Structure of alahopcin (nourseimycin), a new dipeptide antibiotic. J. Antibiot. (Tokyo) 1985;38:302\u2013311. doi: 10.7164/antibiotics.38.302.", "ArticleIdList": ["10.7164/antibiotics.38.302", "3839223"]}, {"Citation": "Xu W, et al. Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of \u03b1-ketoglutarate-dependent dioxygenases. Cancer Cell. 2011;19:17\u201330. doi: 10.1016/j.ccr.2010.12.014.", "ArticleIdList": ["10.1016/j.ccr.2010.12.014", "PMC3229304", "21251613"]}, {"Citation": "Rzem R, Van Schaftingen E, Veiga-da-Cunha M. The gene mutated in l-2-hydroxyglutaric aciduria encodes l-2-hydroxyglutarate dehydrogenase. Biochimie. 2006;88:113\u2013116. doi: 10.1016/j.biochi.2005.06.005.", "ArticleIdList": ["10.1016/j.biochi.2005.06.005", "16005139"]}, {"Citation": "Achouri Y, et al. Identification of a dehydrogenase acting on D-2-hydroxyglutarate. Biochem. J. 2004;381:35\u201342. doi: 10.1042/BJ20031933.", "ArticleIdList": ["10.1042/BJ20031933", "PMC1133759", "15070399"]}, {"Citation": "Peng S, et al. Beyond isocitrate dehydrogenase mutations: Emerging mechanisms for the accumulation of the oncometabolite 2-hydroxyglutarate. Chem. Res. Toxicol. 2022;35:115\u2013124. doi: 10.1021/acs.chemrestox.1c00254.", "ArticleIdList": ["10.1021/acs.chemrestox.1c00254", "35018778"]}, {"Citation": "Thinnes, C. C. et al. Selective inhibitors of a human prolyl hydroxylase (OGFOD1) involved in ribosomal decoding. Chem.\u2013A Eur. J.25, 2019\u20132024 (2019).", "ArticleIdList": ["PMC6471485", "30427558"]}, {"Citation": "Figg WD, Jr, et al. Structural basis of prolyl hydroxylase domain inhibition by molidustat. ChemMedChem. 2021;16:2082\u20132088. doi: 10.1002/cmdc.202100133.", "ArticleIdList": ["10.1002/cmdc.202100133", "PMC8359944", "33792169"]}, {"Citation": "Elkins JM, et al. Structure of factor-inhibiting hypoxia-inducible factor (HIF) reveals mechanism of oxidative modification of HIF-1\u03b1 *. J. Biol. Chem. 2003;278:1802\u20131806. doi: 10.1074/jbc.C200644200.", "ArticleIdList": ["10.1074/jbc.C200644200", "12446723"]}, {"Citation": "Ng SS, et al. Crystal structures of histone demethylase JMJD2A reveal basis for substrate specificity. Nature. 2007;448:87\u201391. doi: 10.1038/nature05971.", "ArticleIdList": ["10.1038/nature05971", "17589501"]}, {"Citation": "Suzuki T, Miyata N. Lysine demethylases inhibitors. J. Med. Chem. 2011;54:8236\u20138250. doi: 10.1021/jm201048w.", "ArticleIdList": ["10.1021/jm201048w", "21955276"]}, {"Citation": "Koivunen P, Hirsil\u00e4 M, G\u00fcnzler V, Kivirikko KI, Myllyharju J. Catalytic properties of the asparaginyl hydroxylase (FIH) in the oxygen sensing pathway are distinct from those of its prolyl 4-hydroxylases*. J. Biol. Chem. 2004;279:9899\u20139904. doi: 10.1074/jbc.M312254200.", "ArticleIdList": ["10.1074/jbc.M312254200", "14701857"]}, {"Citation": "Rose NR, et al. Plant growth regulator daminozide is a selective inhibitor of human KDM2/7 histone demethylases. J. Med. Chem. 2012;55:6639\u20136643. doi: 10.1021/jm300677j.", "ArticleIdList": ["10.1021/jm300677j", "PMC4673902", "22724510"]}, {"Citation": "Shalaby NA, et al. JmjC domain proteins modulate circadian behaviors and sleep in drosophila. Sci. Rep. 2018;8:815. doi: 10.1038/s41598-017-18989-1.", "ArticleIdList": ["10.1038/s41598-017-18989-1", "PMC5770425", "29339751"]}, {"Citation": "Elkins JM, et al. Structure of factor-inhibiting hypoxia-inducible factor (HIF) reveals mechanism of oxidative modification of HIF-1\u03b1*. J. Biol. Chem. 2003;278:1802\u20131806. doi: 10.1074/jbc.C200644200.", "ArticleIdList": ["10.1074/jbc.C200644200", "12446723"]}, {"Citation": "Tarhonskaya H, et al. Kinetic Investigations of the role of factor inhibiting hypoxia-inducible factor (FIH) as an oxygen sensor*. J. Biol. Chem. 2015;290:19726\u201319742. doi: 10.1074/jbc.M115.653014.", "ArticleIdList": ["10.1074/jbc.M115.653014", "PMC4528135", "26112411"]}, {"Citation": "McDonough MA, et al. Cellular oxygen sensing: Crystal structure of hypoxia-inducible factor prolyl hydroxylase (PHD2) Proc. Natl. Acad. Sci. 2006;103:9814\u20139819. doi: 10.1073/pnas.0601283103.", "ArticleIdList": ["10.1073/pnas.0601283103", "PMC1502536", "16782814"]}, {"Citation": "Hewitson KS, et al. Structural and mechanistic studies on the inhibition of the hypoxia-inducible transcription factor hydroxylases by tricarboxylic acid cycle intermediates*. J. Biol. Chem. 2007;282:3293\u20133301. doi: 10.1074/jbc.M608337200.", "ArticleIdList": ["10.1074/jbc.M608337200", "17135241"]}, {"Citation": "Flashman E, et al. Evidence for the slow reaction of hypoxia-inducible factor prolyl hydroxylase 2 with oxygen. FEBS J. 2010;277:4089\u20134099. doi: 10.1111/j.1742-4658.2010.07804.x.", "ArticleIdList": ["10.1111/j.1742-4658.2010.07804.x", "PMC4160827", "20840591"]}, {"Citation": "Abboud MI, et al. 2-Oxoglutarate regulates binding of hydroxylated hypoxia-inducible factor to prolyl hydroxylase domain 2. Chem. Commun. 2018;54:3130\u20133133. doi: 10.1039/C8CC00387D.", "ArticleIdList": ["10.1039/C8CC00387D", "PMC5885369", "29522057"]}, {"Citation": "Chowdhury R, et al. Structural basis for oxygen degradation domain selectivity of the HIF prolyl hydroxylases. Nat. Commun. 2016;7:12673. doi: 10.1038/ncomms12673.", "ArticleIdList": ["10.1038/ncomms12673", "PMC5007464", "27561929"]}, {"Citation": "Otwinowski Z, Minor W. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzym. 1997;276:307. doi: 10.1016/S0076-6879(97)76066-X.", "ArticleIdList": ["10.1016/S0076-6879(97)76066-X", "27754618"]}, {"Citation": "Winn MD, et al. Overview of the {\\it CCP}4 suite and current developments. Acta Crystallogr. Sect. D. 2011;67:235\u2013242. doi: 10.1107/S0907444910045749.", "ArticleIdList": ["10.1107/S0907444910045749", "PMC3069738", "21460441"]}, {"Citation": "McCoy AJ, et al. Phaser crystallographic software. J. Appl. Crystallogr. 2007;40:658. doi: 10.1107/S0021889807021206.", "ArticleIdList": ["10.1107/S0021889807021206", "PMC2483472", "19461840"]}, {"Citation": "Emsley, P. & Cowtan, K. Coot: Model-building tools for molecular graphics. Acta Crystallogr., Sect. Biol. Crystallogr.60, 2126 (2004).", "ArticleIdList": ["15572765"]}, {"Citation": "Adams, P. D. et al. PHENIX: Building new software for automated crystallographic structure determination. Acta Crystallogr., Sect. D Biol. Crystallogr.58, 1948 (2002).", "ArticleIdList": ["12393927"]}, {"Citation": "Terwilliger TC. Improving macromolecular atomic models at moderate resolution by automated iterative model building, statistical density modification and refinement. Acta Crystallogr. Sect. D. 2003;59:1174\u20131182. doi: 10.1107/S0907444903009922.", "ArticleIdList": ["10.1107/S0907444903009922", "PMC2745880", "12832760"]}, {"Citation": "Eberhardt J, Santos-Martins D, Tillack AF, Forli S. AutoDock vina 1.2.0: New docking methods, expanded force field, and python bindings. J. Chem. Inf. Model. 2021;61:3891\u20133898. doi: 10.1021/acs.jcim.1c00203.", "ArticleIdList": ["10.1021/acs.jcim.1c00203", "PMC10683950", "34278794"]}, {"Citation": "Kruidenier L, et al. A selective jumonji H3K27 demethylase inhibitor modulates the proinflammatory macrophage response. Nature. 2012;488:404\u2013408. doi: 10.1038/nature11262.", "ArticleIdList": ["10.1038/nature11262", "PMC4691848", "22842901"]}, {"Citation": "Adams PD, et al. {\\it PHENIX}: A comprehensive python-based system for macromolecular structure solution. Acta Crystallogr. Sect. D. 2010;66:213\u2013221. doi: 10.1107/S0907444909052925.", "ArticleIdList": ["10.1107/S0907444909052925", "PMC2815670", "20124702"]}, {"Citation": "Sch\u00fcttelkopf AW, van Aalten DMF. {\\it PRODRG}: A tool for high-throughput crystallography of protein{\u2013}ligand complexes. Acta Crystallogr. Sect. D. 2004;60:1355\u20131363. doi: 10.1107/S0907444904011679.", "ArticleIdList": ["10.1107/S0907444904011679", "15272157"]}, {"Citation": "Kozakov D, et al. The FTMap family of web servers for determining and characterizing ligand-binding hot spots of proteins. Nat. Protoc. 2015;10:733\u2013755. doi: 10.1038/nprot.2015.043.", "ArticleIdList": ["10.1038/nprot.2015.043", "PMC4762777", "25855957"]}, {"Citation": "Sievers F, et al. Fast, scalable generation of high-quality protein multiple sequence alignments using clustal Omega. Mol. Syst. Biol. 2011;7:539. doi: 10.1038/msb.2011.75.", "ArticleIdList": ["10.1038/msb.2011.75", "PMC3261699", "21988835"]}, {"Citation": "Chowdhury R, et al. Ribosomal oxygenases are structurally conserved from prokaryotes to humans. Nature. 2014;510:422\u2013426. doi: 10.1038/nature13263.", "ArticleIdList": ["10.1038/nature13263", "PMC4066111", "24814345"]}, {"Citation": "Kato M, et al. Crystal structure of a novel JmjC-domain-containing protein, TYW5, involved in tRNA modification. Nucleic Acids Res. 2011;39:1576\u20131585. doi: 10.1093/nar/gkq919.", "ArticleIdList": ["10.1093/nar/gkq919", "PMC3045595", "20972222"]}, {"Citation": "Webby CJ, et al. Jmjd6 catalyses Lysyl-hydroxylation of U2AF65, a protein Associated with RNA splicing. Science. 2009;325:90\u201393. doi: 10.1126/science.1175865.", "ArticleIdList": ["10.1126/science.1175865", "19574390"]}, {"Citation": "Bingsheng C, Yue C, Yingming Z, Bruick RK. JMJD6 is a histone arginine demethylase. Science. 2007;318:444\u2013447. doi: 10.1126/science.1145801.", "ArticleIdList": ["10.1126/science.1145801", "17947579"]}, {"Citation": "Islam MS, et al. Biochemical and structural investigations clarify the substrate selectivity of the 2-oxoglutarate oxygenase JMJD6. J. Biol. Chem. 2019;294:11637\u201311652. doi: 10.1074/jbc.RA119.008693.", "ArticleIdList": ["10.1074/jbc.RA119.008693", "PMC6663879", "31147442"]}, {"Citation": "Markolovic S, et al. The Jumonji-C oxygenase JMJD7 catalyzes (3S)-lysyl hydroxylation of TRAFAC GTPases. Nat. Chem. Biol. 2018;14:688\u2013695. doi: 10.1038/s41589-018-0071-y.", "ArticleIdList": ["10.1038/s41589-018-0071-y", "PMC6027965", "29915238"]}, {"Citation": "Chowdhury R, et al. Conservation of the unusual dimeric JmjC fold of JMJD7 from drosophila melanogaster to humans. Sci. Rep. 2022;12:6065. doi: 10.1038/s41598-022-10028-y.", "ArticleIdList": ["10.1038/s41598-022-10028-y", "PMC9001643", "35410347"]}, {"Citation": "Leissing TM, et al. Factor inhibiting HIF can catalyze two asparaginyl hydroxylations in VNVN motifs of ankyrin fold proteins. J. Biol. Chem. 2022;298:102020. doi: 10.1016/j.jbc.2022.102020.", "ArticleIdList": ["10.1016/j.jbc.2022.102020", "PMC9189129", "35537551"]}, {"Citation": "Wu M, et al. Anti-anemia drug FG4592 retards the AKI-to-CKD transition by improving vascular regeneration and antioxidative capability. Clin. Sci. 2021;135:1707\u20131726. doi: 10.1042/CS20210100.", "ArticleIdList": ["10.1042/CS20210100", "34255035"]}, {"Citation": "Chertow GM, et al. Vadadustat in patients with anemia and non\u2013dialysis-dependent CKD. N. Engl. J. Med. 2021;384:1589\u20131600. doi: 10.1056/NEJMoa2035938.", "ArticleIdList": ["10.1056/NEJMoa2035938", "33913637"]}, {"Citation": "Roda JM, et al. Stabilization of HIF-2\u03b1 induces sVEGFR-1 production from tumor-associated macrophages and decreases tumor growth in a murine melanoma model. J. Immunol. 2012;189:3168 LP\u20133177. doi: 10.4049/jimmunol.1103817.", "ArticleIdList": ["10.4049/jimmunol.1103817", "PMC3436995", "22869907"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "8", "Day": "18"}, {"Year": "2022", "Month": "11", "Day": "10"}, {"Year": "2022", "Month": "11", "Day": "30", "Hour": "23", "Minute": "33"}, {"Year": "2022", "Month": "12", "Day": "1", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "12", "Day": "3", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "11", "Day": "30"}], "PublicationStatus": "epublish", "ArticleIdList": ["36450832", "PMC9712658", "10.1038/s41598-022-24154-0", "10.1038/s41598-022-24154-0"]}}], "PubmedBookArticle": []}